Best of SABCS ® News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide.

SAN ANTONIO, Dec. 1, 2022 /PRNewswire/ -- Encore Medical Education, a US-based medical education company will launch the 2022 edition of the Best of SABCS ^® News Highlights program from the 2022 San Antonio Breast Cancer Symposium (SABCS ^®) starting December 7th.

This official SABCS ^® News Highlights program reached more than 5,000  health care professionals in 2021  from over 50  countries. "Excellent recap of the wide variety of presentations from SABCS ^®. This is such a dense conference that these summary presentations are almost mandatory" said a user who registered in 2021 for program. "The presentations included in these highlights discuss hot scientific topics by experts in the field. The most updated findings are also provided giving great insights regarding the potential advancements in the clinical setting," said another registered user.

A stellar faculty will present their key takeaways with selected original slides from the major trials from #SABCS22 including:

• Outcomes RxPONDER trial
• An update of  TAILORx  trial
• Primary results from the randomized Phase II RIGHT Choice  trial
• Results from RIO-US B-12 TALENT trial
• Results from the Phase III CAPItello-291  trial
• Overall survival results from EMERALD
• Results from multi-dose Phase 2 SERENA-2  trial
• And many others…

The first expert video highlights will be available starting December 7^th at 4PM Central Time (GMT -6 hours). Register today at https://bestofsabcsnews.com/#/home/register and to get daily updates on the most relevant advances in breast cancer  via email.